The International Huntington Association wants to play a key role in bridging the relationship between researchers and individuals by educating people all over the world on Huntington’s disease on the importance of clinical trials, how they can get involved and why participation is crucial.

If you give us the information requested below, rest assured that we will not share it with any pharmaceutical companies or third parties. Our aim is to map the prevalence of HD in different countries so that we are able to present numbers and encourage pharmaceutical companies to set up more trials in different countries.